International Conference on Emerging Focus in Diabetes Research
ICEFDR
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the evolving regulatory landscape affecting diabetes management, including recent policy changes and their implications for clinical practice. Participants will discuss the challenges and opportunities presented by these regulatory trends.
SDG 3
SDG 4
Focusing on the bridge between laboratory research and clinical application, this track will highlight innovative preclinical studies and their potential to transform diabetes treatment. Presentations will cover novel therapeutic targets and methodologies in diabetes research.
SDG 3
SDG 9
This session will address the operational challenges faced by healthcare providers in diabetes management, including care coordination and resource allocation. Discussions will emphasize best practices for optimizing diabetes care delivery.
SDG 3
SDG 10
This track will delve into the physiological mechanisms underlying diabetes and its complications. Participants will examine the latest research on insulin resistance, beta-cell dysfunction, and the role of genetics in diabetes.
SDG 3
SDG 4
This session will focus on current clinical practices in diabetes management, highlighting innovative treatment approaches and patient care strategies. Experts will share insights on optimizing glycemic control and improving patient outcomes.
SDG 3
SDG 4
Participants will explore the latest trends in the prevention and management of diabetes-related complications, such as neuropathy, retinopathy, and cardiovascular disease. The session will emphasize integrated care approaches to mitigate these complications.
SDG 3
SDG 9
This track will review recent advancements in diabetes medications, including novel pharmacological agents and their mechanisms of action. Discussions will also cover personalized medicine approaches in pharmacotherapy for diabetes.
SDG 3
SDG 9
This session will examine the role of alternative therapies and lifestyle interventions in diabetes management, including dietary modifications and physical activity. Participants will discuss evidence-based approaches to complement conventional treatments.
SDG 3
SDG 4
This track will provide insights into the diabetes market, including trends in drug development, market access, and economic evaluations. Participants will analyze the implications of market dynamics for stakeholders in diabetes care.
SDG 8
SDG 9
This session will highlight cutting-edge technologies that are transforming diabetes care, including continuous glucose monitoring and telehealth solutions. Discussions will focus on the integration of technology into clinical practice to enhance patient management.
SDG 3
SDG 9
This track will address the current challenges in endocrinology related to diabetes and explore future research directions. Experts will share their perspectives on emerging issues in endocrine regulation and diabetes management.
SDG 3
SDG 4